Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051742HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20022496HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44015404HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44023634HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44012773HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041591HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041670HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44051073HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047171HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047121HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TCGA Plot Options
Drug Information
GeneESR2
DrugBank IDDB13869
Drug Name2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol
Target IDBE0000792
UniProt IDQ92731
Regulation Type
PubMed IDs26970359
CitationsRonghe A, Chatterjee A, Singh B, Dandawate P, Abdalla F, Bhat NK, Padhye S, Bhat HK: 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors alpha and beta in breast cancer cells. Toxicol Appl Pharmacol. 2016 Jun 15;301:1-13. doi: 10.1016/j.taap.2016.03.003. Epub 2016 Mar 9.
GroupsExperimental
Direct Classification
SMILESCOC1=C(O)C(C=NC2=CC=C(C)C=C2)=CC=C1
Pathways
PharmGKB
ChEMBL